Value of long non-coding RNA TMEVPG1 in prognosis evaluation of patients with primary immune thrombocytopenia

XU Jianhong; CHEN Yuanfeng; ZHU Qing; LIU Lili; LIU Hong; QIAO Mingming

doi:10.7619/jcmp.20221880

Journal of Clinical Medicine in Practice > 2023 > 27(3): 16-20. > DOI: 10.7619/jcmp.20221880

XU Jianhong, CHEN Yuanfeng, ZHU Qing, LIU Lili, LIU Hong, QIAO Mingming. Value of long non-coding RNA TMEVPG1 in prognosis evaluation of patients with primary immune thrombocytopenia[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 16-20. DOI: 10.7619/jcmp.20221880

Citation:

PDF (864 KB)

Value of long non-coding RNA TMEVPG1 in prognosis evaluation of patients with primary immune thrombocytopenia

Department of Apheresis, Shandong Blood Center, Jinan, Shandong, 250014

More Information

Received Date: June 15, 2022
Available Online: March 02, 2023

Graphical Abstract

Abstract

Abstract

Objective
To investigate the value of long non-coding RNA (lncRNA) TMEVPG1 in the prognosis evaluation of patients with primary immune thrombocytopenia (ITP).
Methods
A total of 126 ITP patients were selected as the study group. According to the prognosis of ITP patients, they were divided into poor prognosis group (n=31) and good prognosis group (n=95), and 125 healthy subjects who underwent physical examination during the same period were selected as control group. The relative expression level of lncRNA TMEVPG1 was determined by quantitative real-time polymerase chain reaction (qRT-PCR); correlations of lncRNA TMEVPG1 with platelet count, interferon-γ (IFN-γ), interleukin (IL)-2, IL-4 and IL-10 in ITP patients were explored by Pearson correlation; the factors influencing the prognosis of ITP patients were analyzed by COX regression.
Results
Compared with the control group, lncRNA TMEVPG1 level in the study group was significantly decreased (P < 0.05); lncRNA TMEVPG1 level in the poor prognosis group was significantly lower than that in the good prognosis group (P < 0.05). LncRNA TMEVPG1 was positively correlated with platelet count, IL-4 and IL-10, and negatively correlated with IFN-γ and IL-2 (P < 0.05). Lower lncRNA TMEVPG1 was an independent risk factor for poor prognosis in ITP patients (P < 0.05).
Conclusion
The decreased level of LncRNA TMEVPG1 is associated with poor prognosis in ITP patients, which can be used as an auxiliary indicator to evaluate the prognosis of ITP patients.
- primary immune thrombocytopenia,
- long non-coding RNA TMEVPG1,
- prognosis,
- interleukin-2

FullText(HTML)

References (19)

References

[1]	于慧辉, 詹延霞, 季丽莉, 等. 原发性免疫性血小板减少症(ITP)患者CD5⁺B细胞对CD4⁺T细胞Th1/Th2型细胞因子分泌的影响[J]. 复旦学报: 医学版, 2020, 47(1): 53-58. doi: 10.3969/j.issn.1672-8467.2020.01.010
[2]	COOPER N, GHANIMA W. Immune thrombocytopenia. reply[J]. N Engl J Med, 2020, 382(11): 1077-1078. doi: 10.1056/NEJMc1913324
[3]	SHROPSHIRE S, DOW S, LAPPIN M. Detection and dynamics of anti-platelet antibodies in thrombocytopenic dogs with and without idiopathic immune thrombocytopenia[J]. J Vet Intern Med, 2020, 34(2): 700-709. doi: 10.1111/jvim.15737
[4]	孙妍, 王明镜, 曹新甜, 等. 原发性免疫性血小板减少症患者外周血microRNAs的表达及与Th1/Th2失衡的关系[J]. 中国实验血液学杂志, 2021, 29(5): 1570-1576. doi: 10.19746/j.cnki.issn1009-2137.2021.05.031
[5]	王子叶, 杨堃, 温大蔚, 等. lncRNA MIAT在巨噬细胞炎症反应中的作用[J]. 中国免疫学杂志, 2020, 36(16): 1921-1924, 1930. doi: 10.3969/j.issn.1000-484X.2020.16.001
[6]	MORENIKEJI O B, BERNARD K, STRUTTON E, et al. Evolutionarily conserved long non-coding RNA regulates gene expression in cytokine storm during COVID-19[J]. Front Bioeng Biotechnol, 2020, 8: 582953.
[7]	ZENI P F, MRAZ M. LncRNAs in adaptive immunity: role in physiological and pathological conditions[J]. RNA Biol, 2021, 18(5): 619-632. doi: 10.1080/15476286.2020.1838783
[8]	LI H Y, HAO Y T, ZHANG D L, et al. Aberrant expression of long noncoding RNA TMEVPG1 in patients with primary immune thrombocytopenia[J]. Autoimmunity, 2016, 49(7): 496-502. doi: 10.3109/08916934.2016.1167192
[9]	中华医学会血液学分会止血与血栓学组. 成人原发免疫性血小板减少症诊断与治疗中国专家共识(2016年版)[J]. 中华血液学杂志, 2016, 37(2): 89-93.
[10]	LIU Y, CHEN S J, SUN Y C, et al. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: a retrospective study[J]. Medicine, 2016, 95(50): e5565. doi: 10.1097/MD.0000000000005565
[11]	何栋, 黎杨杨, 陈冬玲. ANA及ANAs在原发性血小板减少症患者诊断中的应用[J]. 锦州医科大学学报, 2020, 41(4): 57-60. https://www.cnki.com.cn/Article/CJFDTOTAL-JZYX202004012.htm
[12]	JEON K, KIM M, LEE J, et al. Immature platelet fraction: a useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery[J]. Medicine, 2020, 99(7): e19096. doi: 10.1097/MD.0000000000019096
[13]	夏芳芳, 胡明智, 孙慧莹, 等. LncRNA在自身免疫性疾病中的研究进展[J]. 中国免疫学杂志, 2019, 35(15): 1907-1912. doi: 10.3969/j.issn.1000-484X.2019.15.023
[14]	王羡, 王红霞, 潘俊斐, 等. lncRNA Tmevpg1对小鼠自噬和JAK-STAT信号通路关键信号分子表达水平的影响[J]. 中国细胞生物学学报, 2019, 41(7): 1308-1319. https://www.cnki.com.cn/Article/CJFDTOTAL-XBZZ201907013.htm
[15]	FAN Z W, WANG X, LI P, et al. Systematic identification of lncRNA-associated ceRNA networks in immune thrombocytopenia[J]. Comput Math Methods Med, 2020, 2020: 6193593.
[16]	DE BENEDITTIS G, CICCACCI C, LATINI A, et al. Emerging role of microRNAs and long non-coding RNAs in sjögren's syndrome[J]. Genes, 2021, 12(6): 903. doi: 10.3390/genes12060903
[17]	李清梅. 益气滋阴摄血汤对原发免疫性血小板减少症患者血清IL-10、IL-17含量的影响[J]. 四川中医, 2021, 39(9): 70-73. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY202109019.htm
[18]	SUAREZ B, PRATS-MARI L, UNFRIED J P, et al. LncRNAs in the type I interferon antiviral response[J]. Int J Mol Sci, 2020, 21(17): 6447.
[19]	FARAHANI E, SOTOODEHNEJADNEMATALAHI F, MAMI S, et al. Up-regulation of Tmevpg1 and rmrp LncRNA levels in splenocytes and brain of mouse with experimental autoimmune encephalomyelitis[J]. Nov Biomed, 2019, 7: 246-253.

Cited By

Get Citation

PDF

XML

Article views (173) PDF downloads (11)

Turn off MathJax

Article Contents

Abstract

References

Value of long non-coding RNA TMEVPG1 in prognosis evaluation of patients with primary immune thrombocytopenia

Abstract

References

Catalog

Export File

Citation

Format

Content